Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04553302
Other study ID # Izmir Katip Celebi University
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 1, 2019
Est. completion date August 30, 2020

Study information

Verified date September 2020
Source Izmir Katip Celebi University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to assess hand functions and wrist joint position sense in patients with and without PsA.


Description:

In this study, 54 patients (18 of them RA, 18 of them PsA and, 18 of them asymptomatic healthy group) were included. The patient group was selected from the patients who came to the Izmir Katip Celebi University Ataturk Training and Research Hospital Rheumatology Outpatient Clinic for routine control.

Participants were matched according to age and gender. It was recorded demographic and clinical data.

Grip and pinch strengths were evaluated within the scope of hand function evaluation. Wrist joint position sense was evaluated along with hand functions.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date August 30, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- to be diagnosed according to CASPAR or ACR/ EULAR 2010 criteria for patient groups

- taking regular medication for patient groups,

- have complaints related to hand / wrist joints for patients groups,

- have no complaints related to upper extremity for asymptomatic healthy group.

- have any rheumatologic disease and OA diagnosed according to traditional criteria

Exclusion Criteria:

- finger infection and / or finger amputation,

- using orthoses,

- to report a diagnosis of neurological disease,

- to report a history of trauma or surgery involving the upper extremity,

- to report a psychiatric and / or cognitive problem

Study Design


Related Conditions & MeSH terms


Intervention

Other:
This study does not contain any intervention.
This study does not contain any intervention.

Locations

Country Name City State
Turkey Izmir Katip Celebi University Ataturk Research and Training Hospital Izmir Izmir/ Cigli

Sponsors (1)

Lead Sponsor Collaborator
Melissa Köprülüoglu

Country where clinical trial is conducted

Turkey, 

References & Publications (5)

Feced Olmos CM, Alvarez-Calderon O, Hervás Marín D, Ivorra Cortés J, Pujol Marco C, Román Ivorra JA. Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients. Clin Biomech (Bristol, Avon). 2019 Aug;68:169-174. doi: 10.1016/j.clinbiomech.2019.06.009. Epub 2019 Jun 11. Erratum in: Clin Biomech (Bristol, Avon). 2020 Feb;72:212. — View Citation

Hudak PL, Amadio PC, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996 Jun;29(6):602-8. Erratum in: Am J Ind Med 1996 Sep;30(3):372. — View Citation

INNES, E. V. Handgrip strength testing: a review of the literature. Australian Occupational Therapy Journal, 1999, 46.3: 120-140.

Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984 Mar;9(2):222-6. — View Citation

Navsarikar A, Gladman DD, Husted JA, Cook RJ. Validity assessment of the disabilities of arm, shoulder, and hand questionnaire (DASH) for patients with psoriatic arthritis. J Rheumatol. 1999 Oct;26(10):2191-4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Grip Strength Grip strenght was examined using a hand dynamometer (Lafayette Proffessional Hand Held Dynamometer, USA). Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Secondary Two-Point Pinch Strength It was evaluated by pinchmeter (Lafayette,USA). Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Secondary Three-Point Pinch Strength It was evaluated by pinchmeter (Lafayette,USA). Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Secondary Lateral Pinch Strength It was evaluated by pinchmeter (Lafayette,USA). Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Secondary DASH score The DASH score provides information about the general functionality of the upper extremity and especially activities of hand. Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
Secondary Wrist Joint Position Sense Wrist joint position sense was evaluated by goniometric re-position error test ( in 30? wrist extansion, 3 repeat ). Data collection will continue until September 2019. Data analysis and report preparation will be completed by August 2020.
See also
  Status Clinical Trial Phase
Completed NCT04152759 - Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects Phase 1
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT01925768 - Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis Phase 3
Completed NCT01892436 - Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis Phase 3
Completed NCT01212770 - PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Phase 3
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Completed NCT01212757 - PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis Phase 3
Completed NCT03953378 - CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis
Recruiting NCT02572700 - Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
Completed NCT02556034 - Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.
Completed NCT02154425 - A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Phase 1
Completed NCT02188654 - Metformin in Psoriatic Arthritis N/A
Completed NCT01392326 - Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) Phase 3
Completed NCT02164214 - Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? Phase 3
Completed NCT01083693 - Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs N/A
Not yet recruiting NCT00517101 - Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy N/A
Completed NCT00133315 - TNFalfa Blocking Treatment of Spondylarthropathies Phase 4
Completed NCT00659412 - A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis Phase 2
Completed NCT00946686 - To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions Phase 1
Not yet recruiting NCT06059430 - Cohort Project of Patients With Inflammatory Rheumatism